Secondary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (S-PLAC 2)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-07

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prescribing lifestyle changes to patients who have cardiovascular disease (CVD) may be an extremely cost effective mechanism of improving health individually and for the NHS. Positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption have been proven to reform the health status of individuals with CVD. S-PLAC 2 is a phase II study to determine the efficacy of a lifestyle prescription (L℞) in patients and healthcare practitioners in a secondary care setting (i.e. hospital clinics/wards).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health

NCT04113213

Behavior Change Interventions Cardiovascular Diseases Cardiovascular Risk Factor +1 more

SUSPENDED NA

Implementation of a Structured Lifestyle Program in Primary Care. Changes in Lifestyle Habits and Cardiovascular Risk.

NCT03681002

Cardiovascular Risk Factor Lifestyle Risk Reduction Primary Care

COMPLETED NA

Feasibility of a Preventive Program Against Lifestyle Related Diseases

NCT02797392

Type-2 Diabetes Cardiovascular Diseases Chronic Obstructive Pulmonary Disease (COPD)

COMPLETED NA

Med-South Lifestyle Program Implementation Study

NCT05067816

Healthy Lifestyle

COMPLETED NA

Change of Lifestyle by Persons in Risk of Type 2 Diabetes

NCT00202748

Type 2 Diabetes

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases Cardiovascular Risk Factor Health Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

The study is an interventional controlled observational study based in the Secondary care setting. Control groups will be utilized through the mechanism of wait-listing the enrolment of recruitment centres into the study.

Mixed methods will be used for both data collection and analysis. Historical clinical participant data (pre-intervention) will be collected by the PI. data will be collected immediately after the consultation and at 3 months post intervention.

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control (Standard Care)

Standard care during consultations. Advice and guidance offered by clinicians verbally and sometimes the addition of leaflets or a referral.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention (Standard Care plus Lifestyle prescription - LRx)

Standard care during consultations with the addition of a physical lifestyle prescription. Advice and guidance will be offered by clinicians verbally, whilst being supported with a lifestyle prescription and a possible referral if required.

Group Type EXPERIMENTAL

Lifestyle Prescription (LRx)

Intervention Type BEHAVIORAL

Standard care during consultations with the addition of a physical lifestyle prescription

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifestyle Prescription (LRx)

Standard care during consultations with the addition of a physical lifestyle prescription

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and over
* Able and willing to provide written informed consent
* Understands written and spoken English
* Either an in/out- patient of Cardiology